Cargando…
Consensus statements from the EAU-ESMO collaboration for advanced and variant bladder cancer: can we move the needle to improve survival?
Autor principal: | Packiam, Vignesh T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807307/ https://www.ncbi.nlm.nih.gov/pubmed/33457222 http://dx.doi.org/10.21037/tau-20-934 |
Ejemplares similares
-
Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast
por: Filicevas, Alex, et al.
Publicado: (2022) -
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast
por: Filicevas, Alex, et al.
Publicado: (2023) -
Parma consensus statement on metabolic disruptors
por: Heindel, Jerrold J., et al.
Publicado: (2015) -
A commentary on the “consensus statement” regarding the use of BIAsp30
por: Kawamori, Ryuzo
Publicado: (2010) -
Consensus statement for the perinatal management of patients with α thalassemia major
por: MacKenzie, Tippi C., et al.
Publicado: (2021)